bimagrumab glp 1 Lilly stops trial of muscle-sparing obesity drug Obesity research is moving beyond

Sarnelli G, Pesce M, Barbara G, de Bortoli N, Sario AD, Esposito G, Frazzoni M, Galloro G, Gatta L, Ghisa M, Londoni C, Marabotto E, Meggio A, Pisani A, Ribolsi M, Usai Satta P, Savarino V, Scarpignato C, Stanghellini V, Tosetti C, Visaggi P, Zingone F, Barberio B, Savarino EV (2025) Italian guidelines for the diagnosis and treatment of functional dyspepsiajoint consensus from the Italian societies of gastroenterology and endoscopy (SIGE), neurogastroenterology and motility (SINGEM), hospital gastroenterologists and endoscopists (AIGO), digestive endoscopy (SIED) and general medicine (SIMG)

Toporkova, Y.Y., Smirnova, E.O., Gorina, S.S

Contact me for information about buying or selling

GLP-1 RAs do not increase cancer risk in patients with T2DM